BTBD10 and central nervous system cancer: Our findings that BTBD10 was downregulated in human glioma tissue and that BTBD10 overexpression exerted anti-proliferative effects in U251 cells do not agree with these previous reports, which suggests that the functional effects of BTBD10 in glioma cells may differ from those in other cell types.